Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. (RPHM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RPHM · as of Jun 9, 2026
Key Statistics
Explore Reneo Pharmaceuticals, Inc. Data
rphm stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
Competitors & Peers
rphm competitorsRPHM
ACHL
ALVR
HTBX
KRON
QNCXAbout Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to creating therapies for individuals suffering from uncommon inherited mitochondrial disorders. Th…
what is reneo pharmaceuticals, inc. · rphm stock overview · reneo pharmaceuticals, inc. company profile · who is reneo pharmaceuticals, inc. ceo · rphm NASDAQ · reneo pharmaceuticals, inc. headquarters · reneo pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Reneo Pharmaceuticals, Inc. (RPHM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 8, 2021. As of the latest trading session, RPHM stock price is $18.20, with a market capitalization of $60.8M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Reneo Pharmaceuticals, Inc. (RPHM) stock price is $18.20. The stock is traded on NASDAQ under the ticker symbol RPHM. The 52-week range is $1.68 – $82.90.